Clinical Trials Directory

Trials / Completed

CompletedNCT02333448

Evaluate the Performance of Genetic Amplification by Polymerase Chain Reaction (PCR) and the "Mannan Antigenemia and Antimannan Antibodies Couple as a Means of Diagnosis and a Marker of Follow-up in Invasive Candidiasis.

Diagnostic Value of PCR Genetic Amplification and Mannan Antigenemia Coupled With Antimannan Antibodies in Intensive Care Patients With Suspected Invasive Candidiasis

Status
Completed
Phase
Study type
Observational
Enrollment
80 (actual)
Sponsor
Centre Hospitalier Universitaire Dijon · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The study consists in taking 4 tubes of blood at different times over a period of 10 days, via a catheter (central venous or arterial catheter) already in place in the usual therapeutic management. These samples will make it possible to measure blood levels of certain markers specific to invasive candidiasis. PCR will be used to quantify fungal load precisely, that is to say the quantity of yeast present in the blood and to monitor this quantity over time. These samples will be transferred to a specialized unit and stored for a maximum of three years for use at the end of the study.

Conditions

Interventions

TypeNameDescription
BIOLOGICALBlood sample taken on the day the treatment is initiated
BIOLOGICALBlood sample taken on day 3 after initiation of treatment
BIOLOGICALBlood sample taken on day 5 after initiation of
BIOLOGICALBlood sample taken on day 7 after initiation of treatment
BIOLOGICALBlood sample taken on day 10 after initiation of treatment

Timeline

Start date
2015-06-12
Primary completion
2019-09-17
Completion
2019-09-17
First posted
2015-01-07
Last updated
2024-02-20

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02333448. Inclusion in this directory is not an endorsement.